院外心脏骤停患者在接受体外心肺复苏后使用主动脉内球囊反搏的情况
该研究基于日本院外心脏骤停注册数据(2014年6月至2019年12月),回顾性分析2135例接受ECPR的成人(≥18岁)OHCA患者,其中1173例使用IABP。经倾向性评分匹配后842例配对患者中,IABP使用与30天生存相关(aOR 1.98;95%CI 1.39-2.83;p<0.001);但在190例存活患者中,IABP使用与30天神经功能良好预后无显著关联(aOR 1.22;95%CI 0.79-1.89;p=0.36)。作者认为需要进一步设计良好的前瞻性研究。
要点
- 在842例倾向性评分匹配后的ECPR后OHCA患者中,IABP使用与30天生存相关(aOR 1.98;95%CI 1.39-2.83;p<0.001)。
- 在190例存活患者中,IABP使用与30天神经功能良好预后无显著关联(aOR 1.22;95%CI 0.79-1.89;p=0.36)。
- 研究纳入2014年6月至2019年12月日本OHCA注册中≥18岁、接受ECPR的成人患者,共2135例,其中1173例接受IABP。
- 作者结论认为,IABP使用与30天生存相关,但与存活者神经功能预后无显著关联,需进一步前瞻性研究。
适用人群与场景
- 日本OHCA注册中2014年6月至2019年12月期间接受ECPR的成人(≥18岁)院外心脏骤停患者。
研究设计与关键结果
- 回顾性分析日本OHCA注册数据,纳入2135例接受ECPR的成人OHCA患者,其中1173例接受IABP;采用多重插补处理缺失数据后行倾向性评分匹配,匹配后842例。
- 匹配后842例中,IABP使用与30天生存相关(aOR 1.98;95%CI 1.39-2.83;p<0.001)。
- 190例存活患者中,IABP使用与30天神经功能良好预后无显著关联(aOR 1.22;95%CI 0.79-1.89;p=0.36)。
证据类型、等级与局限
- 回顾性注册研究,作者指出需要进一步设计良好的前瞻性研究。
对床旁实践的改变
- 作者认为,在ECPR后的OHCA患者中,IABP使用与30天生存相关;在存活患者中,IABP使用与30天神经功能良好预后无显著关联,需进一步前瞻性研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To investigate the effect of intra-aortic balloon pump (IABP) use after extracorporeal membrane oxygenation-assisted cardiopulmonary resuscitation (ECPR) on short-term neurological outcomes and survival in patients with out-of-hospital cardiac arrest (OHCA).
METHODS: We retrospectively analysed data collected between June 2014 and December 2019 from the Japanese OHCA registry. Adult patients (aged ≥18 years) who underwent ECPR were included. We divided the patients into those who received IABP and those who did not receive IABP. The primary outcome was the 30-day favourable neurological outcomes in survived patients. The secondary outcome was the 30-day survival. We performed propensity score matching (PSM) to adjust for confounding factors after multiple imputations of missing data. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were estimated using logistic regression analysis after PSM to adjust for confounding factors after IABP initiation.
RESULTS: Among 2135 adult patients who underwent ECPR, 1173 received IABP. In 842 matched patients, IABP use was associated with survival (aOR, 1.98; 95% CI, 1.39-2.83; p < 0.001). However, IABP use was not significantly associated with the 30-day neurologically favourable outcome in 190 survived patients (aOR, 1.22; 95% CI, 0.79-1.89; p = 0.36).
CONCLUSION: The use of IABP in patients with OHCA who underwent ECPR was associated with 30-day survival. Among survived patients, there was no significant association between IABP use and 30-day neurological outcome. A further well-designed prospective study is needed.
参考来源
- Kashiura M, Kishihara Y, Ozawa H, et al. Intra-aortic balloon pump use in out-of-hospital cardiac arrest patients who underwent extracorporeal cardiopulmonary resuscitation. Resuscitation. 2022. PMID: 36481238. doi:10.1016/j.resuscitation.2022.11.026
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。